M4 QUALITATIVE PLATELET DISORDERS (ACQUIRED) Flashcards

1
Q

structural and functional modifications of
arachidonic acid pathway enzymes

A

ASPIRIN-LIKE DEFECTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

inhibition of cyclooxygenase

A

ASPIRIN-LIKE DEFECTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

absence or abnormalities of the components of the
thromboxane pathway

A

ASPIRIN-LIKE DEFECTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ibuprofen

A

Inhibits platelet function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Thromboxane -

A

Activate neighboring platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bleeding caused by platelet dysfunction

A

UREMIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

UREMIA:
Circulating ____ or ___ Interference

A

guanidinosuccinic acid (GSA) or
hydroxy phenolic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GSA (Guanidinosuccinic Acid) is a ____

A

NO (Nitric Oxide)
donor which is a platelet inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COX INHIBITOR

A

ACETYLSALICYLIC ACID (ASPIRIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACETYLSALICYLIC ACID (ASPIRIN)
Interferences:

A
  1. Platelet membrane receptor sites
  2. Prostaglandin synthesis
  3. Phosphodiesterase activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

competitive inhibitors of cyclooxygenase

A

IBUPROFEN AND RELATED COMPOUNDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COX-1 (Irreversible)

A

Aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

COX-1 (reversible)

A

Naproxen
Sulfinpyrazone
Ibuprofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ADP P2Y12 (Irreversible)

A

Clopidogrel
Prasurgel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADP P2Y12 (reversible)

A

Ticagrelor
Cangrelor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Thrombin PAR-1

A

Vorapaxar

17
Q

Sticky Platelet Syndrome

A

HYPERAGGREGABLE PLATELETS

18
Q

autosomal dominant, thrombophilic disorder that is
associated with venous and arterial thromboembolic
events.

A

STICKY PLATELET SYNDROME

19
Q

Overactivation of the agonist

A

STICKY PLATELET SYNDROME

20
Q

aggregation in response to
in vitro stirring only

A

spontaneous aggregation

21
Q

Stormorken

A

Fibrin Clot

22
Q

Sticky Platelet

A

Platelet Clot

23
Q

Autosomal
dominant

A

vWF disease
Quebec platelet
Sticky Platelet
Syndrome

24
Q

Autosomal
recessive

A

-Bernard-Soulier
syndrome
-Glanzmann
thrombasthenia
-Gray platelet
syndrome
-Thrombocytopenia absent radius (TAR)
syndrome
-Hermansky-Pudlak
syndrome

25
Q

X-linked

A

Wiskott-Aldrich
syndrome
Scott syndrome

26
Q

no aggregation with natural agonists
- Because there is qualitative or
quantitative defect of GP αIIbβ3

A

Glanzmann
thrombasthenia
(Abnormal Clot
retraction)

27
Q

decreased Thrombin generation
- Because phosphatidylserine cannot
translocate to the outer layer

A

scott

28
Q

lack of adhesion to VWF and abnormal
response to thrombin
- Deficiency or mutation on GP: IX,
Ibβ, and Ibα

A

Bernard-Soulier
syndrome

29
Q

spontaneous binding of VWF to GP Ibα
- Result of binding: they are removed
from the circulation

A

Platelet-type
VWD
(Type 2B)

30
Q

Gray Platelet Syndrome
Quebec Platelet Disorder
α-Dense granule-storage pool deficiency
Wiskott-Aldrich Syndrome

A

α-Granules

31
Q

G-proteins
Phospholipases

A

Signaling
pathways

32
Q

Hermansky-Pudlak syndrome
Chediak-Higashi syndrome
Dense granule-storage pool deficiency
Wiskott-Aldrich Syndrome

A

Dense granules

33
Q

Cyclooxygenase
TXA2 synthase
Lipoxygenase
(Drug induced)

A

Enzymes in
dense tubular
system

34
Q

Giant Platelet syndromes
● Large platelets
Wiskott-Aldrich syndrome
● Micro Platelets or micro
thrombocytes formation

A

Cytoskeleton